Autism Spectrum Disorder Screening Practices in the United States and Mexico
DOI:
https://doi.org/10.51734/crdr.v3i2.53Abstract
Purpose: The purpose of this study was to explore screening practices for autism spectrum disorder (ASD) in Mexico and the United States (U.S.).
Methods: Data from a larger study exploring the knowledge, screening, and diagnostic practices of healthcare practitioners from Mexico and the U.S. was used for the current study. The original survey was created by experts in ASD and consisted of 63 questions: 15 demographic questions, 20 questions relating to knowledge of ASD, 11 questions relating to screening practices, and 17 questions relating to diagnostic practices. All surveys were completed by professionals engaging in the screening and diagnosis of ASD. For this study, a total of thirty- five survey responses for the screening portion of the survey (30 from the U.S. and 5 from Mexico) were explored. Qualitative data and descriptive statistics were utilized.
Results: Many of the responses relating to screening practices from professionals practicing in Mexico and the U.S. were consistent with best practice guidelines from the Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP), and the Mexican Public Health Guide. Furthermore, many similarities were found in the screening practices of professionals from both countries. Differences in screening practices reported by professionals from Mexico and the U.S. were found in the type of professional involved in the screening process and professional referrals after a failed ASD screening. Additionally, some professionals from both the U.S. and Mexico reported the use of inappropriate screening tools, and the average age reportedly screened was much higher than the current recommendations of the American Academy of Pediatrics (Hyman et al., 2020).
Conclusion: An understanding of the screening practices currently being used in Mexico and the U.S. provides both researchers and clinicians with a better understanding of what is being implemented by different professionals. This study identified areas of strength and areas of weaknesses in the screening process for ASD in both countries. These results can now be used in future studies and programs targeting improved screening processes in Mexico in the U.S. Improved screening processes are important because of the potential to result in an earlier age of diagnosis of ASD and provision of services at a younger age. The latter of which is associated with better outcomes for children with ASD.
Keywords: autism spectrum disorder, screening, Mexico, United States.
References
References
Albores-Gallo, L., Hernández-Guzmán, L., Díaz-Pichardo, J. A., & Cortes- Hernández, B. (2008). Dificultades en la evaluación y diagnóstico del autismo: Una discusión. Salud Mental, 31(1), 37-44.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5.
Washington, DC: American Psychiatric Association.
Bravo Oro, A., Esmer, C., & Navarro- Calvillo, M. (2014). Autism Spectrum Disorders in Mexico. Comprehensive Guide to Autism, 2469–2482.
Campbell, A., & Duarte, F. (1993). Impacto de ASD en la Familia: La Percepción de los Padres. Noticieras Televise, ASDo: Profundo Silencios, and Carlos Marcin, Una Visión (dis)Pareja, Araru, 1, 1-5.
Centers for Disease Control and Prevention. (2021). Prevalence of autism spectrum disorders among children aged 8 years— Autism and developmental disabilities monitoring network, 11 sites, United States, 2016. Morbidity and Mortality Weekly Report.
Surveillance Summaries, 70(1), 1–
Centers for Disease Control and Prevention. (2020). Prevalence of autism spectrum disorders among children aged 8 years— Autism and developmental disabilities monitoring network, 11 sites, United States, 2016. Morbidity and Mortality Weekly Report.
Surveillance Summaries, 69(4), 1–
Centers for Disease Control and Prevention. (2018). Prevalence of autism spectrum disorders among children aged 8 years— Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morbidity and Mortality Weekly Report.
Surveillance Summaries, 63(2), 1–
Centers for Disease Control and Prevention. (2020). Spotlight On: Delay Between First Concern to Accessing Services. https://www.cdc.gov/ncbddd/autism/ addm-community-report/delay-to- accessing- services.html#:~:text=Of%20the%20 children%20who%20received,limitin g%20the%20s ervices%2 0they%20receive.
Centers for Disease Control and Prevention.
N.D. Screening and Diagnosis of Autism Spectrum Disorder. https://www.cdc.gov/ncbddd/autism/s creening.html#:~:text=Diagnosing%2 0autism%20spectrum%20disorder%2 0(ASD,at%2018%20months%20or% 20younger.
Cohen, S. & Miguel, J. (2018). Amor and social stigma: ASD beliefs among immigrant Mexican parents. Journal of Autism and Developmental Disorders, 48(6), 1995-2009.
Estes, A., Munson, J., Rogers, S., Greenson, J., Winter, J., & Dawson, G. (2015). Long-term outcomes of early intervention in 6-year old children with autism spectrum disorder.
Journal of the American Academy of Child and Adolescent Psychiatry, 54 (7), 580-587.
Fombonne, E., Marcin, C., Manero, A. C., Bruno, R., Diaz, C., Villalobos, M., & Nealy, B. (2016). Prevalence of autism spectrum disorders in
Guanajuato, Mexico: The Leon survey. Journal of Autism and Developmental Disorders, 46(5),
-1685.
Glascoe FP.(1997) Parents' Evaluations of Developmental Status: A Method for Detecting and Addressing Developmental and Behavioral Problems in Children. Nashville, TN: Ellsworth & Vandermeer Press.
Harris, B., & Barton, E. E. (2017). Autism services in Mexico: A qualitative survey of education professionals. International Journal of School & Educational Psychology, 5(1), 1-13.
Hyman, S., Levy, S., Myers, S., & Council on Children with Disabilities, Section on Developmental and behavioral pediatrics. 2020.
Identification, Evaluation, and Management of Children with Autism Spectrum Disorder.
Pediatrics, 145(1), 1-69.
Johnson C. & Myers S. (2007). American academy of pediatrics council on children with disabilities.
Identification and evaluation of children with autism spectrum disorders. Pediatrics, 120(5), 1183–
Marquez-Caraveo, M., & Albores-Gallo, L. (2011). Autistic spectrum disorders: Diagnostic and therapeutic challenges in Mexico. Salud Mental, 34(5), 435–441.
Robins, D. L., Fein, D., Barton, M. L., & Green, J. A. (2001). The Modified Checklist for Autism in Toddlers: An initial study investigating the early detection of autism and pervasive developmental disorders. Journal of autism and developmental disorders, 31(2), 131–144.
https://doi.org/10.1023/a:101073882 9569.
Robins, D. L., Fein, D., & Barton, M. (2009). The modified checklist for autism in toddlers, revised with follow-up (M-CHAT-R/F).
Santana, S., & Santana, F. (2001). An Introduction to Mexican Culture for Rehabilitation Service Providers.
Center for International Research Information and Exchange (CIRRIE). Albany, NY: State University of New York.
Secretaría de Salud (2012). Diagnóstico y Tratamiento de los Trastornos del Espectro Autista. México: Secretaría de Salud.
Squires, J. & Bricker, D. (2009). Ages & Stages Questionnaires[R], Third Edition (ASQ-3[TM]): A Parent- Completed Child-Monitoring System. Brookes Publishing Company.
Stone, W., & Ousley, O. Y. (2008). Screening Tool for Autism in Toddlers and Young Children (STAT). Vanderbilt University.
Sullivan, K., Stone, W.L., & Dawson, G. (2014). Potential neural mechanisms underlying the effectiveness of early intervention for children with autism spectrum disorder. Research in Developmental Disabilities, 35(11),
-2932.
Tuman, J. P., Roth-Johnson, D., Baker, D. L., & Vecchio, J. (2008). Autism and special education policy in Mexico. Global Health Governance, II (1), 1–
U.S. Census Bureau. (2017). Quick Facts: United States. https://www.census.gov/quickfacts/fa ct/table/US/PST045216.
U.S. Census Bureau. (2019). Quick Facts: Population estimates. https://www.census.gov/quickfacts/fac t/table/US/PST045219.
Wetherby, A. M. & Prizant, B. M. (2003).
Communication and Symbolic Behavior Scales Developmental Profile. Brookes Publishing Company.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Maria F Valdez, Jessica R. Stewart, Ruth Crutchfield, Wan-Lin Chang, Ralph Carlson
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
